Key trends and challenges are shaping the next era of advanced therapies, from FDA momentum to broader patient access.

An increase in hospitalizations related to respiratory disease was found in older adults in the western US. “This information ...

Nipocalimab (Imaavy; Johnson & Johnson), an FcRn-blocking monoclonal antibody, was approved for patients 12 years and older ...

Results presented on Tuesday at the American Association for Cancer Reserch include data on the combined use of tissue and ...

Mike Fazio, director of value-based care at Navista, Cardinal Health, discusses a trending topic at the 2025 Community ...

A panelist discusses how the HIV patient population has aged significantly, with the average age in their clinic now ...

A panelist discusses how viral suppression in HIV patients means achieving undetectable virus levels (below 50 or 20 copies ...

Oncology leaders from Alliance Cancer Specialists, American Oncology Network, CHI St. Vincent, Memorial Sloan Kettering ...

Strategic relationships and feedback can enhance specialty pharmacy operations, said Natalie Bedford, senior vice president of US pharmaceutical distribution services at McKesson.

“These observations may be the result of direct metabolic or proinflammatory effects of weight fluctuation, as has been suggested in some mouse studies, or may be related to changes in health status ...

Jon Giles, MD, speaks to the power of personalized medicine and multidisciplinary care to enhance treatment for patients with ...

At Asembia’s AXS25 Summit, industry experts explored how pharmacy is evolving to meet rising patient expectations and ...